GlassScriptPhysician profile
Jose C Martin
NPI 1861429425
$3,141.55
in general payments reported to CMS, 2019-2025
13 companies · $548 in 2025
The $548 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $476 · 2020: $68.46 · 2021: $1,024 · 2022: $652 · 2023: $186 · 2024: $187 · 2025: $548.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $921.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $920.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,193.30 | 2021-2025 | Micra, Aurora Ev-Icd Mri Surescan, Cobalt Dr Mri Surescan |
| Medtronic Vascular, INC. | $364.28 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $130.51 | 2019-2021 | |
| Amgen INC. | $111.16 | 2019-2021 | |
| Amarin Pharma, INC. | $103.22 | 2021 | |
| Philips North America LLC | $64.68 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $43.04 | 2021-2024 | Farxiga |
| Boston Scientific Corporation | $36.86 | 2019-2025 | General - Therapies |
| Masimo Corporation | $23.33 | 2025 | Set and Rainbow Set |
| Abbott Laboratories | $22.35 | 2025 | Assurity |
| Smith+Nephew, INC. | $19.06 | 2019 | |
| Siemens Medical Solutions USA, INC. | $16.15 | 2023 | Magnetom Altea |
| E.R. Squibb & Sons, L.L.C. | $13.61 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Martin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.